BBLG (bonebiologics.com) Earnings per share growth this year

Official company branding of Bone Biologics Inc (BBLG)

Bone Biologics (BBLG) is optimizing implant production by reducing waste and adhering to bioethics. Measurable YoY EPS growth confirms the impact of these strategies, with the indicator currently standing at 55.60. Bone Biologics (BBLG) is advancing bone regeneration via the NELL-1 platform for spinal restoration. Additionally, the developer strictly follows material disposal standards within sterile zones.

BBLG (Bone Biologics Corporation) Earnings per share growth in current year history from 07/04/2022 to 11/14/2026

Financial and market metric breakdowns for Bone Biologics (BBLG)

- stock value and consensus price forecast:
Market Price Bone Biologics Corp.|BBLG - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Bone Biologics Inc|BBLG - Real Price to Acquire Entire Company
- book capitalization information:
Accounting Value of a Share Bone Biologics|BBLG - Company Book Value|Market Cap to Net Assets Ratio bonebiologics.com|BBLG - Company Total Assets
- debt and solvency information:
Debt to Capital Bone Biologics|BBLG - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio bonebiologics.com|BBLG - Company Aggregate Debts|Debts to Net Assets Bone Biologics Inc|BBLG - Company Long-Term Debts|Company Current Liabilities Bone Biologics|Quick Ratio bonebiologics.com
- net income and valuation multiples indicators:
BBLG - Company Net Income|Expected Profit Bone Biologics|BBLG - Price to Earnings Ratio|Future Price to Earnings Multiple Bone Biologics Inc|BBLG - PEG Multiple|Company Value to EBITDA Bone Biologics Inc|BBLG - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year Bone Biologics|BBLG - Net earnings per share for the last 12 months|Quarterly EPS earnings growth bonebiologics.com|BBLG - Earnings growth in current year|Consensus forecast of earnings per share growth for next year Bone Biologics
- revenue and sales proceeds data:
BBLG - Company Revenue|Company Expected Revenue Bone Biologics Corp.|BBLG - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Bone Biologics Inc
Fundamental valuation:BBLG - Bone Biologics Corp.
Signature product of Bone Biologics Corp.

For Bone Biologics, the efficiency of protein synthesis automation directly impacts operating margins and bottom-line net income. This metric measures the percentage deviation of current earnings per share from the same period last year, revealing the real-time growth dynamics of business profitability. By analyzing the annual EPS growth indicator, an investor can assess the company's stability and promptly recognize a fundamental trend reversal.

Direct competitors

Earnings per share growth rate in current year Boston Scientific Corp (BSX)|EW (Edwards Lifesciences Corp) - Earnings growth in current year|Earnings per share growth this year RMD (ResMed Corporation)|Net earnings per share growth this year PODD (Insulet Corporation)|ZBH (Zimmer Biomet Holdings, Inc.) - Earnings per share increase in current year|Earnings per share growth in current year CooperCompanies COO|ALGN - Net earnings per share growth this year|Globus Medical Corp - Earnings growth in current year|Earnings per share growth rate in current year TransMedics Group|ATEC: Earnings growth in current year|Earnings per share growth this year AORT|ENOV (Enovis) - Earnings growth in current year|Integra LifeSciences Corp (IART) - Expected net earnings per share growth this year|Earnings growth in current year ESTA|Net earnings per share growth this year iLet Bionic Pancreas BBNX|Earnings growth in current year IRMD (IRADIMED CORPORATION)|Earnings growth in current year embecta.com EMBC|TNDM - Earnings per share growth in current year|AXGN: Earnings per share growth in current year|SIBN (SI-BONE Corp) - Net earnings per share growth this year|Orthofix Corp - Earnings per share increase in current year|BVS (Bioventus Inc.) - Earnings growth in current year|Earnings per share growth rate in current year OrthoPediatrics Inc. KIDS|Earnings per share growth in current year Treace Medical Concepts, Inc. (TMCI)|Blade Air Mobility (SRTA) - Net earnings per share change in current year|Carlsmed Corp - Net earnings per share growth this year|Earnings growth in current year RxSight Ophthalmic RXST|ClearPoint - Earnings growth in current year|Expected net earnings per share growth this year stereotaxis.com STXS|Neuronetics (STIM) - Earnings per share growth in current year|Earnings per share trend in current year SGHT (Sight Sciences Inc.)|Earnings per share growth in current year Orchestra BioMed, Inc.|Net earnings per share growth this year Anika (ANIK)|Earnings growth in current year NSPR|ZJYL - Earnings per share growth rate in current year|Earnings per share growth in current year Vivani Medical VANI|XTNT: Earnings per share growth this year|NMTC: Net earnings per share growth this year|Modular Medical - Net earnings per one share growth for the current year|MYO: Earnings growth in current year|COCH (envoymedical.com) - Earnings per share growth in current year|Earnings per share growth in current year Vivos Therapeutics, Inc.|Earnings per share growth rate in current year enVVeno Medical Corporation NVNO|Earnings per share growth in current year Sintx Technologies (SINT)|Tenon Medical Inc - Earnings per share growth this year|Earnings growth in current year LFWD (ReWalk Robotics Ltd.)|Autonomix Medical Inc. (AMIX) - Earnings per share growth rate in current year|IVF: Net earnings per share growth this year|Earnings per share increase in current year AXNX (Axonics Inc.)|BIOL: Earnings growth in current year|DYNT (Dynatronics) - Earnings per share growth in current year|FNA (Paragon 28 Inc.) - Earnings growth in current year|INVO Bio (INVO) - Expected net earnings per share growth this year